// App-Quantinova.ai

: The impact of age on treatment for pancreatic ductal adenocarcinoma (PDAC) with curative intent: is age a barrier?

Researchers

Presenter

  • A.K. Malik

Principal Investigators

  • A. Lamarca

  • A.K. Siriwardena

  • D.A. O'Reilly

  • R. Deshpande

  • A. Sheen

  • S. Jamdar

  • M.G. McNamara

  • J.W. Valle

  • N. De Liguori-Carino

Medical Centers

  • Department of HPB Surgery, Manchester Royal Infirmary, United Kingdom

  • Department of Medical Oncology, European Neuroendocrine Tumour Society (ENETS) Centre of Excellence, The Christie NHS Foundation Trust, United Kingdom

  • Division of Cancer Sciences, Manchester Academic Health Science Centre, University of Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

  • Microphthalmia, syndromic, 9

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved